In patients with MDS, GLP-1 RA use was associated with less transformation to acute myeloid leukemia (AML), lower morality rates as well as reduced cytopenic complications, acute kidney injury and VTE
GLP-1 medications, or glucagon-like peptide-1 receptor agonists, are cutting-edge treatments designed to aid in weight loss and improve metabolic health
Gender Differences in the Context of Obstructive Sleep Apnea and Metabolic Diseases Allen, J., & Bradley, R.D
Wellness Seekers Enhance immunity, detoxify the body, and support overall health with targeted nutrient blends
They support collagen and tissue repair: A healthy scalp environment is essential for producing strong, resilient hair
Additionally, dysesthesia was reported at a higher rate with Wegovy HD compared to Wegovy 2.4 mg and placebo in clinical trials.2 Events related to a clinical picture of altered skin sensation such as sensitive skin, hyperesthesia, dysesthesia and paresthesia were reported by a higher proportion of participants, and at a higher rate, in the Wegovy HD arm (22%), compared to treatment with Wegovy 2.4 mg (6%) and placebo (0.3%).1,2 Novo Nordisk continues to meet patients where they seek care and expand affordable options to access authentic, FDA-approved Wegovy
